IDC10 Code = C49
Genomic coordinate (human 12:46,000,001 MXLPO).
Cytoband (human 12q13.11 MXLPO).
OMIM’ genes @ 12q13.11 = 12 genes.
Hyperbolic Umbilic Chromosome-12 is 1,200 genes.
Chromosome-12 Cytobands: WG2B2GC_CBG5B2G6 (12/29)
Here I 🎁 present: “Myxoid Liposarcoma”, Victor McKusick, Mendelian Inheritance in Man’, 1966. (MXLPO)
INTRODUCTION.
NR3C1 (Nuclear Receptor Subfamily 3, Group C, Member 1) is the gene encoding the Glucocorticoid Receptor (GR). In Myxoid Liposarcoma (MLPS), its role revolves around its interaction with the master driver oncogene DDIT3 (also known as CHOP).
Because DDIT3’s native biological role is to alter GR (NR3C1) signaling during cellular stress, the FUS::DDIT3 fusion protein found in MLPS directly manipulates this nuclear receptor pathway to maintain its malignant state.
🧬 The Molecular Link: DDIT3 and NR3C1
In normal biology, DDIT3 (CHOP) is a major protein triggered during severe endoplasmic reticulum (ER) stress.
- The Normal Stress Response: Under cell stress, DDIT3 physically interacts with and binds to the Glucocorticoid Receptor (NR3C1). This interaction alters the transcriptional activity of NR3C1, preventing it from carrying out its normal survival or metabolic programs and often pushing a stressed cell toward apoptosis (programmed cell death).
- The Sarcoma Highjack: In Myxoid Liposarcoma, the FUS::DDIT3 fusion protein preserves the functional binding domain of DDIT3. Consequently, the fusion oncogene actively hijacks, suppresses, or dysregulates the transcription patterns normally controlled by NR3C1 across adipocytes, contributing heavily to the characteristic block in cell differentiation.
🧪 Therapeutic Implications of NR3C1 in MLPS
Understanding the interaction between the FUS::DDIT3 oncogene and the NR3C1 receptor has opened up distinct avenues for research and treatment:
- Glucocorticoid Resistance: In many lymphoid and solid tumors, synthetic glucocorticoids (like dexamethasone) are used to induce cell death through NR3C1 signaling. However, because the FUS::DDIT3 oncogene structurally alters or blunts normal NR3C1 activity, Myxoid Liposarcomas exhibit a distinct resistance to standard glucocorticoid-induced apoptosis.
- Crosstalk with PPAR-γ (NR1C3): Adipogenesis (fat cell development) requires a delicate balance between PPAR-γ and GR (NR3C1) In MLPS, the fusion protein disrupts this dual-receptor network. Differentiation therapies aimed at forcing the tumor to mature often look at how activating PPAR-γ can bypass the downstream blocks that the oncogene imposes on the NR3C1 pathway.
